SINGAPORE, Aug 2 (Bernama-BUSINESS WIRE) — Prestige BioPharma Limited (PBP)’s IPO lock-up will be partially released on August 4, 2021. PBP is the first Singapore based company to be listed on the Korea Composite Stock Price Index (KOSPI). IPO process usually requires early investors and insiders to lock-up their stock for at least 180 days.
Amid this season of uncertainty, PBP’s major institutional shareholders shared their confidence in the company’s potential future growth and the Sputnik COVID19 vaccine CMO business.